160 related articles for article (PubMed ID: 9684796)
1. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration.
Suffredini AF; Reda D; Banks SM; Tropea M; Agosti JM; Miller R
J Immunol; 1995 Nov; 155(10):5038-45. PubMed ID: 7594512
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor.
van der Poll T; Coyle SM; Kumar A; Barbosa K; Agosti JM; Lowry SF
J Immunol; 1997 Feb; 158(3):1490-7. PubMed ID: 9013996
[TBL] [Abstract][Full Text] [Related]
4. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
8. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
Eason JD; Wee S; Kawai T; Hong HZ; Powelson JA; Widmer MB; Cosimi AB
Transplantation; 1995 Jan; 59(2):300-5. PubMed ID: 7839455
[TBL] [Abstract][Full Text] [Related]
10. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
Fisher CJ; Agosti JM; Opal SM; Lowry SF; Balk RA; Sadoff JC; Abraham E; Schein RM; Benjamin E
N Engl J Med; 1996 Jun; 334(26):1697-702. PubMed ID: 8637514
[TBL] [Abstract][Full Text] [Related]
11. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
Steinshamn S; Bemelmans MH; Buurman WA; Waage A
Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
[TBL] [Abstract][Full Text] [Related]
12. Dobutamine does not influence inflammatory pathways during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-protein diet and protein supplementation on the expressions of TNF-alpha, TNFR-I, and TNFR-II in organs and muscle of LPS-injected rats.
Raina N; Jeejeebhoy KN
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E481-7. PubMed ID: 14625205
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor necrosis factor-alpha reduces alveolar septal cell apoptosis in passive smoking rats.
Zhang C; Cai S; Chen P; Chen JB; Wu J; Wu SJ; Zhou R
Chin Med J (Engl); 2008 Apr; 121(7):597-601. PubMed ID: 18466678
[TBL] [Abstract][Full Text] [Related]
18. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.
Suffredini AF; Harpel PC; Parrillo JE
N Engl J Med; 1989 May; 320(18):1165-72. PubMed ID: 2496309
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]